Today Mustang Bio Incorporated (NASDAQ:MBIO) Reported Increase in Shorted Shares

February 15, 2018 - By Marie Mckinney

 Today Mustang Bio Incorporated (NASDAQ:MBIO) Reported Increase in Shorted Shares

The stock of Mustang Bio Incorporated (NASDAQ:MBIO) registered an increase of 81.16% in short interest. MBIO’s total short interest was 37,500 shares in February as published by FINRA. Its up 81.16% from 20,700 shares, reported previously. With 92,500 shares average volume, it will take short sellers 0 days to cover their MBIO’s short positions.

The stock decreased 1.94% or $0.21 during the last trading session, reaching $10.61. About 26,953 shares traded. Mustang Bio, Inc. (NASDAQ:MBIO) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products based on the chimeric antigen receptor engineered T cell technology. The company has market cap of $276.41 million. The Company’s lead programs include MB-101 for the treatment of brain cancer that is in Phase I trials; and MB-102, a therapeutic agent in acute myeloid leukemia, which is in Phase I trials. It currently has negative earnings. The firm was incorporated in 2015 and is based in New York, New York.

More notable recent Mustang Bio, Inc. (NASDAQ:MBIO) news were published by: Globenewswire.com which released: “Mustang Bio to Participate in LifeSci Advisors Corporate Access Event in San …” on December 14, 2017, also Globenewswire.com with their article: “Mustang Bio Announces Appointment of Manuel Litchman, MD, as President and …” published on April 24, 2017, Globenewswire.com published: “Mustang Bio Commences Trading on the NASDAQ Global Market” on August 22, 2017. More interesting news about Mustang Bio, Inc. (NASDAQ:MBIO) were released by: Globenewswire.com and their article: “Fortress Biotech Announces that its Subsidiary, Mustang Bio, Enters into …” published on June 05, 2017 as well as Globenewswire.com‘s news article titled: “Mustang Bio Reports First Quarter 2017 Financial Results and Recent Corporate …” with publication date: May 15, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.